BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25132271)

  • 1. The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53.
    Thomas A; Perry T; Berhane S; Oldreive C; Zlatanou A; Williams LR; Weston VJ; Stankovic T; Kearns P; Pors K; Grand RJ; Stewart GS
    Oncogene; 2015 Jun; 34(25):3336-48. PubMed ID: 25132271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
    Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
    Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIα inhibitor.
    Guo L; Liu X; Jiang Y; Nishikawa K; Plunkett W
    Mol Pharmacol; 2011 Aug; 80(2):321-7. PubMed ID: 21546556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2, a novel anthracenedione, elicits a potent DNA damage response that can be subverted through checkpoint kinase inhibition to generate mitotic catastrophe.
    Evison BJ; Pastuovic M; Bilardi RA; Forrest RA; Pumuye PP; Sleebs BE; Watson KG; Phillips DR; Cutts SM
    Biochem Pharmacol; 2011 Dec; 82(11):1604-18. PubMed ID: 21889927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 5-Iodotubercidin as a genotoxic drug with anti-cancer potential.
    Zhang X; Jia D; Liu H; Zhu N; Zhang W; Feng J; Yin J; Hao B; Cui D; Deng Y; Xie D; He L; Li B
    PLoS One; 2013; 8(5):e62527. PubMed ID: 23667485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells.
    Wu CC; Huang KF; Yang TY; Li YL; Wen CL; Hsu SL; Chen TH
    PLoS One; 2015; 10(7):e0132052. PubMed ID: 26147394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.
    Drummond CJ; Finlay GJ; Broome L; Marshall ES; Richardson E; Baguley BC
    Invest New Drugs; 2011 Oct; 29(5):1102-10. PubMed ID: 20567995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells.
    Kwok M; Davies N; Agathanggelou A; Smith E; Oldreive C; Petermann E; Stewart G; Brown J; Lau A; Pratt G; Parry H; Taylor M; Moss P; Hillmen P; Stankovic T
    Blood; 2016 Feb; 127(5):582-95. PubMed ID: 26563132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
    Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
    Demidova AR; Aau MY; Zhuang L; Yu Q
    J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac.
    Wartlick F; Bopp A; Henninger C; Fritz G
    Biochim Biophys Acta; 2013 Dec; 1833(12):3093-3103. PubMed ID: 23999236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterigmatocystin-induced DNA damage triggers G2 arrest via an ATM/p53-related pathway in human gastric epithelium GES-1 cells in vitro.
    Zhang D; Cui Y; Shen H; Xing L; Cui J; Wang J; Zhang X
    PLoS One; 2013; 8(5):e65044. PubMed ID: 23705030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
    Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
    Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of p53 on Ser15 during cell cycle caused by Topo I and Topo II inhibitors in relation to ATM and Chk2 activation.
    Zhao H; Traganos F; Darzynkiewicz Z
    Cell Cycle; 2008 Oct; 7(19):3048-55. PubMed ID: 18802408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.
    Agathanggelou A; Smith E; Davies NJ; Kwok M; Zlatanou A; Oldreive CE; Mao J; Da Costa D; Yadollahi S; Perry T; Kearns P; Skowronska A; Yates E; Parry H; Hillmen P; Reverdy C; Delansorne R; Paneesha S; Pratt G; Moss P; Taylor AMR; Stewart GS; Stankovic T
    Blood; 2017 Jul; 130(2):156-166. PubMed ID: 28495793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents.
    Lang F; Cornwell JA; Kaur K; Elmogazy O; Zhang W; Zhang M; Song H; Sun Z; Wu X; Aladjem MI; Aregger M; Cappell SD; Yang C
    Neuro Oncol; 2024 Jun; 26(6):1083-1096. PubMed ID: 38134889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of topoisomerase IIalpha and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials.
    Guo L; Liu X; Nishikawa K; Plunkett W
    Mol Cancer Ther; 2007 May; 6(5):1501-8. PubMed ID: 17513599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis.
    Negi SS; Brown P
    Oncotarget; 2015 Jul; 6(20):18094-104. PubMed ID: 26061708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.
    Zimmermann M; Arachchige-Don AS; Donaldson MS; Dallapiazza RF; Cowan CE; Horne MC
    J Biol Chem; 2012 Jun; 287(27):22838-53. PubMed ID: 22589537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.